ALLMedicine™ Behçet Disease Center

Jan 14th, 2023 - Endothelial dysfunction (ED) has a well-known role in promoting vascular inflammation in Behçet disease (BD). α-klotho is involved in regulation of endothelial function, and its reduction has been reported to be associated with ED. To assess serum...

Jan 13th, 2023 - Study design: Prospective cohort study. Sample size: 40 eyes of adult patients with complete Behçet's disease associated uveitis either male or female will be included in the study. Inclusion Criteria: Adult patients with complete Behçet's disease...

Dec 20th, 2022 - Behçet Disease is a relapsing and remitting variable vessel vasculitis characterized by recurrent mucocutaneous ulcers that can involve almost every organ system in the body. Indeed, the presence of recurrent oral or genital ulcers with other auto...

Dec 19th, 2022 - INTRODUCTION 1.1 BACKGROUND Psoriasis and Psoriatic Arthritis Psoriasis is a chronic relapsing immunologically mediated skin disease manifesting as red scaly plaques, which affects about 1-3% of the population.(ref.1-3). Ten to 20% of the people w...

Nov 11th, 2022 - Teaching NeuroImage: Mobile Hypopyon as a Clinical Clue for the Diagnosis of Behçet Disease.|2022|Melo de Almeida I,Rezende Filho FM,Pedroso JL,Barsottini O,|

Feb 5th, 2008 - To develop evidence-based European League Against Rheumatism (EULAR) recommendations for the management of Behçet disease (BD) supplemented where necessary by expert opinion. The multidisciplinary expert committee, a task force of the EULAR Standi...

Jan 13th, 2023 - Study design: Prospective cohort study. Sample size: 40 eyes of adult patients with complete Behçet's disease associated uveitis either male or female will be included in the study. Inclusion Criteria: Adult patients with complete Behçet's disease...

Dec 19th, 2022 - INTRODUCTION 1.1 BACKGROUND Psoriasis and Psoriatic Arthritis Psoriasis is a chronic relapsing immunologically mediated skin disease manifesting as red scaly plaques, which affects about 1-3% of the population.(ref.1-3). Ten to 20% of the people w...

Jun 21st, 2022 - this study is a phase 2, multi-center, randomized, placebo-controlled, double-blind, parallel-group study to evaluate Hemay005 efficacy and safety of the treatment of patients with Behçet Disease(BD). Around 252 subjects will be randomized into th...

Dec 3rd, 2021 - Behçet's disease (BD) was first described by Turkish dermatologist Hulusi Behçet in 1937 as a triad of recurrent oral aphthae, genital ulcerations and relapsing uveitis (1). Behçet disease (BD) is an inflammatory vasculopathy with multisystemic in...

Nov 22nd, 2021 - Behçet disease (BD) is a chronic systemic inflammatory disorder at the crossroad between autoimmune and autoinflammatory syndromes. Two recent large genome-wide association studies (GWAS) conducted in Turkey and Japan reported association between...

Jul 12th, 2022 - On the basis of the patient's medical history and presentation, this is probably a case of uveitis, a common extra-articular manifestation of psoriatic disease. In fact, the presence of uveitis can help distinguish PsA from osteoarthritis.

Apr 7th, 2021 - Apremilast is a small-molecule biologic approved by the US Food and Drug Administration (FDA) for use in plaque psoriasis, psoriatic arthritis, and Behçet disease. 1-6 Although apremilast is seemingly a less favorable choice for treating psoriasis.

Dec 5th, 2020 - Introduction Hairy cell leukemia (HCL) is a rare lymphoid malignancy.1 HCL accounts for only 2% of all lymphoid leukemias, with 600 to 800 new cases diagnosed in the United States each year.1,2 The name of the disease is attributed to the appeara...

Jan 6th, 2020 - Drug Approvals for Rare Dermatologic Diseases On July 19, 2019, apremilast, a phosphodiesterase 4 inhibitor, became the first medication approved by the FDA for the treatment of adults with oral ulcers due to Behçet disease, a rare multisystem inf.

Oct 28th, 2019 - Knee pain and stiffness can be debilitating and difficult to treat. Lifestyle-limiting knee conditions may negatively affect body image and emotional well-being. Weight management, exercise/strengthening programs, physical therapy, physical modali...